|
1
|
Maddodi N and Setaluri V: Role of UV in
cutaneous melanoma. Photochem Photobiol. 84:528–536. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Sauer AM, Chen MS Jr,
Kagawa-Singer M, Jemal A and Siegel RL: Cancer statistics for Asian
Americans, Native Hawaiians, and Pacific Islanders, 2016:
Converging incidence in males and females. CA Cancer J Clin.
66:182–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu T and Du Y: lncRNAs: From basic
research to medical application. Int J Biol Sci. 13:295–307. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brown CJ, Hendrich BD, Rupert JL,
Lafrenière RG, Xing Y, Lawrence J and Willard HF: The human XIST
gene: Analysis of a 17 kb inactive X-specific RNA that contains
conserved repeats and is highly localized within the nucleus. Cell.
71:527–542. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clark MB, Amaral PP, Schlesinger FJ,
Dinger ME, Taft RJ, Rinn JL, Ponting CP, Stadler PF, Morris KV,
Morillon A, et al: The reality of pervasive transcription. PLoS
Biol. 9:e1000625discussion e1001102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang HM, Yang FQ, Chen SJ, Che J and
Zheng JH: Upregulation of long non-coding RNA MALAT1 correlates
with tumor progression and poor prognosis in clear cell renal cell
carcinoma. Tumour Biol. 36:2947–2955. 2015. View Article : Google Scholar
|
|
9
|
Gao K, Ji Z, She K, Yang Q and Shao L:
Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and
promotes glioma cell progression by activation of the Notch
signaling pathway. Biomed Pharmacother. 87:555–560. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.
|
|
11
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E
remodels the melanocyte transcriptome and induces BANCR to regulate
melanoma cell migration. Genome Res. 22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang L, Zhang W, Su B and Yu B: Long
noncoding RNA HOTAIR is associated with motility, invasion, and
metastatic potential of metastatic melanoma. BioMed Res Int.
2013:2510982013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pasmant E, Sabbagh A, Vidaud M and Bièche
I: ANRIL, a long, noncoding RNA, is an unexpected major hotspot in
GWAS. FASEB J. 25:444–448. 2011. View Article : Google Scholar
|
|
15
|
Rapicavoli NA and Blackshaw S: New meaning
in the message: Noncoding RNAs and their role in retinal
development. Dev Dyn. 238:2103–2114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the Notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7:136162016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang L, Wang W, Li G, Sun C, Ren Z, Sheng
H, Gao H, Wang C and Yu H: High TUG1 expression is associated with
chemotherapy resistance and poor prognosis in esophageal squamous
cell carcinoma. Cancer Chemother Pharmacol. 78:333–339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017.PubMed/NCBI
|
|
19
|
Sun J, Ding C, Yang Z, Liu T, Zhang X,
Zhao C and Wang J: The long non-coding RNA TUG1 indicates a poor
prognosis for colorectal cancer and promotes metastasis by
affecting epithelial-mesenchymal transition. J Transl Med.
14:422016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma
P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in
hepatocellular carcinoma and promotes cell growth and apoptosis by
epigenetically silencing of KLF2. Mol Cancer. 14:1652015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma B, Li M, Zhang L, Huang M, Lei JB, Fu
GH, Liu CX, Lai QW, Chen QQ and Wang YL: Upregulation of long
non-coding RNA TUG1 correlates with poor prognosis and disease
status in osteosarcoma. Tumour Biol. 37:4445–4455. 2016. View Article : Google Scholar
|
|
22
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iliev R, Kleinova R, Juracek J, Dolezel J,
Ozanova Z, Fedorko M, Pacik D, Svoboda M, Stanik M and Slaby O:
Overexpression of long non-coding RNA TUG1 predicts poor prognosis
and promotes cancer cell proliferation and migration in high-grade
muscle-invasive bladder cancer. Tumour Biol. 37:13385–13390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang PQ, Wu YX, Zhong XD, Liu B and Qiao
G: Prognostic significance of overexpressed long non-coding RNA
TUG1 in patients with clear cell renal cell carcinoma. Eur Rev Med
Pharmacol Sci. 21:82–86. 2017.PubMed/NCBI
|
|
25
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Downregulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar
|
|
26
|
Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long
C, Pei Z and Fa-Ming T: lncRNA TUG1 is upregulated and promotes
cell proliferation in osteosarcoma. Open Med (Wars). 11:163–167.
2016.
|
|
27
|
Li G, Liu K and Du X: Long Non-Coding RNA
TUG1 Promotes proliferation and inhibits apoptosis of osteosarcoma
cells by sponging miR-132-3p and upregulating SOX4 expression.
Yonsei Med J. 59:226–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Zhou G, Fu X, Cui H, Pu G, Xiao Y,
Sun W, Dong X, Zhang L, Cao S, et al: Long noncoding RNA TUG1 is a
diagnostic factor in lung adenocarcinoma and suppresses apoptosis
via epigenetic silencing of BAX. Oncotarget. 8:101899–101910.
2017.PubMed/NCBI
|
|
29
|
Li J, An G, Zhang M and Ma Q: Long
non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells.
Biochem Biophys Res Commun. 477:743–748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mazar J, Sinha S, Dinger ME, Mattick JS
and Perera RJ: Protein-coding and non-coding gene expression
analysis in differentiating human keratinocytes using a
three-dimensional epidermal equivalent. Mol Genet Genomics.
284:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View Article : Google Scholar
|
|
34
|
Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li
SQ, Wang CM, Tong YS, Tuo L, Wu M, et al: Long noncoding RNA
SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and
associated with poor prognosis. Tumour Biol. 35:7743–7754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao Z, Wang B, Hao J, Man W, Chang Y, Ma
S, Hu Y, Liu F and Yang J: Downregulation of the long non-coding
RNA taurine- upregulated gene 1 inhibits glioma cell proliferation
and invasion and promotes apoptosis. Oncol Lett. 15:4026–4032.
2018.PubMed/NCBI
|
|
36
|
Jiang H, Hu X, Zhang H and Li W:
Down-regulation of lncRNA TUG1 enhances radiosensitivity in bladder
cancer via suppressing HMGB1 expression. Radiat Oncol. 12:652017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cao J, Han X, Qi X, Jin X and Li X: TUG1
promotes osteosarcoma tumorigenesis by upregulating EZH2 expression
via miR-144-3p. Int J Oncol. 51:1115–1123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu J, Shi H, Liu H, Wang X and Li F: Long
non-coding RNA TUG1 promotes cervical cancer progression by
regulating the miR-138-5p-SIRT1 axis. Oncotarget. 8:65253–65264.
2017.PubMed/NCBI
|
|
39
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tian S, Guo X, Yu C, Sun C and Jiang J:
miR-138-5p suppresses autophagy in pancreatic cancer by targeting
SIRT1. Oncotarget. 8:11071–11082. 2017.PubMed/NCBI
|
